OrbusNeich Medical Group Holdings Ltd
HKEX:6929
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
OrbusNeich Medical Group Holdings Ltd
HKEX:6929
|
HK |
|
Hi-Tech Gears Ltd
NSE:HITECHGEAR
|
IN |
|
Westport Fuel Systems Inc
TSX:WPRT
|
CA |
|
PAVmed Inc
NASDAQ:PAVM
|
US |
|
Shenzhen Envicool Technology Co Ltd
SZSE:002837
|
CN |
|
J
|
John Menzies PLC
XBER:B3N
|
UK |
|
Eldorado Gold Corp
TSX:ELD
|
CA |
Wall Street
Price Targets
Price Targets Summary
OrbusNeich Medical Group Holdings Ltd
According to Wall Street analysts, the average 1-year price target for OrbusNeich Medical Group Holdings Ltd is 6.73 HKD with a low forecast of 6.46 HKD and a high forecast of 7.14 HKD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is OrbusNeich Medical Group Holdings Ltd's stock price target?
Price Target
6.73
HKD
According to Wall Street analysts, the average 1-year price target for OrbusNeich Medical Group Holdings Ltd is 6.73 HKD with a low forecast of 6.46 HKD and a high forecast of 7.14 HKD.
What is OrbusNeich Medical Group Holdings Ltd's Revenue forecast?
Projected CAGR
7%
For the last 4 years the compound annual growth rate for OrbusNeich Medical Group Holdings Ltd's revenue is 12%. The projected CAGR for the next 2 years is 7%.
What is OrbusNeich Medical Group Holdings Ltd's Operating Income forecast?
Projected CAGR
5%
For the last 4 years the compound annual growth rate for OrbusNeich Medical Group Holdings Ltd's operating income is 19%. The projected CAGR for the next 3 years is 5%.
What is OrbusNeich Medical Group Holdings Ltd's Net Income forecast?
Projected CAGR
37%
The compound annual growth rate of OrbusNeich Medical Group Holdings Ltd's net income for the next 2 years is 37%.
